We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.16%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.39B
AUM Growth
-$42.4M
(-1.7%)
Cap. Flow
-$177M
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
16.2%
Holding
256
New
23
Increased
45
Reduced
142
Closed
31
Top Buys
| 1 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$25.7M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
+$17.7M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
+$13.3M |
| 4 |
PDCE
PDC Energy, Inc.
PDCE
|
+$13.2M |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$12.4M |
Top Sells
| 1 |
Veeva Systems
VEEV
|
+$45M |
| 2 |
Take-Two Interactive
TTWO
|
+$19.4M |
| 3 |
MSCC
Microsemi Corp
MSCC
|
+$18.7M |
| 4 |
Exelixis
EXEL
|
+$15.4M |
| 5 |
Generac Holdings
GNRC
|
+$14.9M |
Sector Composition
| 1 | Technology | 20.31% |
| 2 | Industrials | 18.87% |
| 3 | Healthcare | 15.79% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Financials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Dave & Buster's
PLAY
$354M
| $13.2M | 0.55% |
197,759
-9,750
| -5% | -$638K |
|
77
MaxLinear
MXL
$6.43B
| $13M | 0.54% |
464,640
+31,105
| +7% | +$906K |
|
|
RETA
78
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $12.9M | 0.54% |
406,426
+36,227
| +10% | +$891K |
|
|
BHVN
79
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.4M | 0.52% |
+497,880
| New | +$11.5M |
|
|
GTHX
80
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $12.4M | 0.52% |
+710,456
| New | +$12.4M |
|
81
Applied Optoelectronics
AAOI
$8.22B
| $12.2M | 0.51% |
196,851
-85,339
| -30% | -$4.99M |
|
82
Integer Holdings
ITGR
$3.24B
| $11.8M | 0.49% |
273,230
-278,130
| -50% | -$11.1M |
|
83
Metallus
MTUS
$807M
| $11.5M | 0.48% |
748,778
-38,190
| -5% | -$566K |
|
|
AIMT
84
DELISTED
Aimmune Therapeutics
AIMT
| $11.5M | 0.48% |
558,946
-24,620
| -4% | -$470K |
|
85
Freshpet
FRPT
$2.78B
| $11.2M | 0.47% |
676,504
+100,918
| +18% | +$1.39M |
|
86
NeoGenomics
NEO
$1.9B
| $11.2M | 0.47% |
1,248,371
-26,489
| -2% | -$210K |
|
87
Red Robin
RRGB
$130M
| $11.1M | 0.47% |
170,783
+101,140
| +145% | +$6.42M |
|
88
Cleveland-Cliffs
CLF
$5.29B
| $11M | 0.46% |
1,587,421
-104,237
| -6% | -$690K |
|
89
Box
BOX
$4.22B
| $10.8M | 0.45% |
+592,400
| New | +$10.7M |
|
|
PDCE
90
DELISTED
PDC Energy, Inc.
PDCE
| $10.8M | 0.45% |
+250,166
| New | +$13.2M |
|
|
CHUY
91
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $10.5M | 0.44% |
449,771
-22,010
| -5% | -$607K |
|
|
MODN
92
DELISTED
MODEL N, INC.
MODN
| $10.5M | 0.44% |
789,070
+42,890
| +6% | +$513K |
|
|
ELLI
93
DELISTED
Ellie Mae Inc
ELLI
| $9.69M | 0.4% |
88,174
-7,145
| -7% | -$773K |
|
94
Manitowoc
MTW
$468M
| $9.46M | 0.4% |
393,406
-18,098
| -4% | -$423K |
|
95
CNB Financial Corp
CCNE
$1.02B
| $9.32M | 0.39% |
389,003
-20,899
| -5% | -$486K |
|
|
ADMS
96
DELISTED
Adamas Pharmaceuticals
ADMS
| $9.32M | 0.39% |
532,727
+14,042
| +3% | +$232K |
|
|
IPHI
97
DELISTED
INPHI CORPORATION
IPHI
| $8.99M | 0.38% |
262,142
+71,420
| +37% | +$2.87M |
|
98
Churchill Downs
CHDN
$5.85B
| $8.96M | 0.37% |
293,442
-305,640
| -51% | -$8.65M |
|
99
MacroGenics
MGNX
$285M
| $7.96M | 0.33% |
454,345
-22,915
| -5% | -$437K |
|
|
ECOM
100
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $7.62M | 0.32% |
659,935
-34,607
| -5% | -$401K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, Emerald Advisers held 256 positions worth $2.39B, down 1.7% from $2.44B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Emerald Advisers withdrew a net $177M in Q2 2017, closing 31 positions and reducing 142 holdings. Its most notable exit was Exelixis, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Emerald Advisers opened a new position in Hostess Brands, Inc. Class A Common Stock worth $25.6M.
- Emerald Advisers's largest Q2 2017 buy was Hostess Brands, Inc. Class A Common Stock: 1,591,603 shares worth $25.6M.
- Emerald Advisers added most to bluebird bio in Q2 2017, an estimated $12.3M increase.
- Emerald Advisers's biggest Q2 2017 reduction was Veeva Systems, cutting an estimated $45M.
- Emerald Advisers fully exited Exelixis in Q2 2017, selling an estimated $15.4M.
- Emerald Advisers's ten largest holdings make up 16% of its $2.39B portfolio in Q2 2017.
- Emerald Advisers opened 23 new positions and closed 31 in Q2 2017.
- Emerald Advisers's portfolio value fell 1.7% quarter-over-quarter to $2.39B.
Based on Emerald Advisers's 13F filing for Q2 2017, filed 28 Jul 2017.